Links
Organizations
Conferences
Info & Opinion
July 20, 2008
Rocket Man
On NASA, BBC and GSK
The industry’s image takes another hit in Britain. Unsolicited advice on avoiding similar encounters.
Business As Usual
Wyeth on FDAAA
Joseph Camardo spoke at the Post-Approval Summit at Harvard, and was wicked smart. Even so, what he didn’t say perturbed us.
Litigation Into Perpetuity?
Drug Safety: A Lawyer’s View
A lawyer says litigation illuminates how the pharmaceutical industry thinks and conducts itself. A few forward-looking statements.
Trasylol, Bayer & Three Mile Island
Drug Safety Story Time
Reflections on the power of narrative and the industry’s wobbly reputation.
- Home
- Tag
- demonization
Is there a more wasteful federal program than NASA? Does it matter if a robot can land on some planet and take a picture of itself digging a small hole? It’s clear that NASA is both useless and popular. Which…
Because of the random sighting of Ira Spector at one conference or another, we’ve always had a soft spot for Wyeth. We don’t know Spector—no need to fret he has been consorting with the news media. But from remarks by…
When will the drug safety wars end? How will they end? A new president? A Supreme Court decision? We thought Tom Lamb might know. He’s an attorney based in Wilmington, North Carolina. Like it or not, lawyers like Lamb are…
With the Oscars upon us, it’s time to reflect on something simple. Our brains store information and make sense of the world in stories. This is true in all cultures, all individuals. “She saved my career.” “They worked it out.”…
Earlier this month, after months of negotiations, Merck announced a large but manageable $4.85 billion settlement of an unknown number of Vioxx plaintiffs who can prove they took the drug and suffered strokes or heart attacks. Those plaintiffs still have…
A few years ago, thinking the way all journalists think, we had an epiphany. The reportorial brain is the one we’re happily stuck with. But it often adopts a harshly negative, critical outlook that transcends age, geography and political affiliation.…
The Post-Approval Summit at Harvard, now in its third year, is the most cerebral conference on our calendar. It is also the meeting most larded with VIP speakers, including a preponderance of physicians who run a) large swaths of international…
There’s another wrinkle in the Ketek story. The Wall Street Journal reports on the Congressional testimony of Ann Marie Cisneros. She’s a former employee of Pharmaceutical Product Development (PPD), a leading contract research organization with $1.26 billion in revenues in…
In the aftermath of 9/11, Newsweek did a cover story on the roots of Islamic hostility to the U.S. That story was titled “Why They Hate Us.” As 2007 begins, the same unsettling question can be asked of the life…
